President Trump’s executive order suspending federal funding for gain-of-function research not only contains questionable assertions, but it also frames the targeted research so broadly that it is likely to affect even lower-risk infectious disease research.
Related Posts
Pediatric Healthcare Insights With Rob Klein
How can today’s pediatricians truly connect with time-crunched, digitally-savvy parents and build lasting loyalty? In this episode, I sit down with Rob Klein, Principal of […]
Why WeightWatchers Filed for Bankruptcy
WeightWatchers has long been a household name, boosted by celebrity endorsements from Oprah Winfrey and Jennifer Hudson. Jean Nidetch founded the New York City company […]
Microplastics Are Here, There, Everywhere – The Health Care Blog
By KIM BELLARD Vaccine experts are going rogue in response to RFK Jr’s attacks on vaccine safety. Health insurers promise – honest…this time – to […]